Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN-Reference-Cited by-同舟云学术

Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN

Published:2024-08 Issue: Volume:274 Page:32-45
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Nicholls Stephen J.,Nelson Adam J.,Ditmarsch Marc,Kastelein John J.P.,Ballantyne Christie M.,Ray Kausik K.,Navar Ann Marie,Nissen Steven E.,Golberg Anne C.,Brunham Liam R.,Curcio Danielle,Wuerdeman Erin,Neild Annie,Kling Douglas,Hsieh Andrew,Dicklin Mary R.,Ference Brian A.,Laufs Ulrich,Banach Maciej,Mehran Roxana,Catapano Alberico L.,Davidson Michael H.

Publisher

Elsevier BV

Reference63 articles.

1. Global Burden of Cardiovascular D, Risks C. Global Burden of Cardiovascular Diseases and Risks, 1990-2022;Mensah;J Am Coll Cardiol,2023

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel;Boren;Eur Heart J,2020

5. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease;Current Opinion in Endocrinology, Diabetes & Obesity;2024-08-05

2. Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis;Journal of Cardiovascular Development and Disease;2024-05-16

3. Obicetrapib: There is still Life in the CETP Inhibitor!;Journal of Atherosclerosis and Thrombosis;2024